Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2013 Oct 4;6(6):10.1161/CIRCIMAGING.113.000674. doi: 10.1161/CIRCIMAGING.113.000674

Figure 5.

Figure 5

Clodronate-liposome treatments preserve tissue integrity, evaluate by H&E tissue staining of (A) an isograft and (B–D) three allografts hearts. Untreated isograft and allograft hearts on POD 7 are shown in (A) and (B); (C) a clodronate-liposome treated allograft on POD 7, which reveals decreased damage to the tissue of the graft compared to the untreated allograft on the same day (B); (D) a clodronate-liposome treated allograft on POD 9.